360 High-Risk Vulnerability Immunization Tool V2.0 vs Greenbone OPENVAS BASIC: 2026 Comparison

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

Greenbone OPENVAS BASIC

Small and mid-market security teams with limited budgets will find real value in Greenbone OPENVAS BASIC because it covers the major vendor stacks (Oracle, Microsoft, Cisco, VMware, Palo Alto) without forcing you into expensive multi-year contracts. The on-premises deployment model means no recurring SaaS fees, and LDAP/Radius integration handles authentication without extra tooling. Skip this if you need continuous monitoring with automated response; OPENVAS BASIC prioritizes the scan-and-report workflow over real-time anomaly detection, leaving the response half of your risk cycle understaffed.